# PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

> **NCT02088775** · NA · COMPLETED · sponsor: **Fox Chase Cancer Center** · enrollment: 44 (actual)

## Conditions studied

- Adult Primary Hepatocellular Carcinoma
- Advanced Adult Primary Liver Cancer
- Metastatic Extrahepatic Bile Duct Cancer
- Recurrent Adult Primary Liver Cancer
- Recurrent Extrahepatic Bile Duct Cancer
- Stage D Adult Primary Liver Cancer (BCLC)
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **PROCEDURE:** PET scan
- **PROCEDURE:** CT Scan
- **PROCEDURE:** hepatic artery embolization

## Key facts

- **NCT ID:** NCT02088775
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2016-08-08
- **Final completion:** 2021-07-30
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02088775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02088775, "PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02088775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*